Clinical verification of automatic local citrate anticoagulant apparatus before registration

Clinical verification of automatic local citrate anticoagulant apparatus before registrat

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000036737

Enrollment

Unknown

Registered

2020-08-25

Start date

2020-10-01

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic kidney disease

Interventions

two-phase group:two-phase calcium supplementation

conventional trail group:conventional trail

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Acute kidney injury with hyperkalemia or metabolic acidosis; 2. Volume overload irreversible with diuretic; 3. Hypercatabolic; 4. MODS.

Exclusion criteria

Exclusion criteria: 1. Application of drugs containing citrate within 72h; 2. Engagement in other clinical trial; 3. Failure to establish vessel access.

Design outcomes

Primary

Measure	Time frame
ionized calcium concentration;	—

Countries

China

Contacts

Public ContactFeng Ding

The Ninth People's Hospital affiliated to Shanghai Jiaotong University School of Medicine

dingfeng@sjtu.edu.cn+86 18919790062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026